Utah Medical Products, Inc.
$70.22
▲
0.4%
2026-04-21 10:04:01
www.utahmed.com
NMS: UTMD
Explore Utah Medical Products, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$225.9 M
Current Price
$70.22
52W High / Low
$71.81 / $51.26
Stock P/E
20.02
Book Value
$37.43
Dividend Yield
1.77%
ROCE
9.51%
ROE
9.54%
Face Value
—
EPS
$3.48
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
140
Beta
0.35
Debt / Equity
0.24
Current Ratio
37.62
Quick Ratio
34.57
Forward P/E
—
Price / Sales
5.48
Enterprise Value
$124.42 M
EV / EBITDA
7.92
EV / Revenue
3.23
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Net margin remains healthy.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Milestone Scientific Inc. | $0.29 | — | $23.33 M | — | -155% | -1.32% | $1.11 / $0.22 | $0.04 |
| 2. | AtriCure, Inc. | $28.79 | — | $1.51 B | — | -1.65% | -2.4% | $43.18 / $27.26 | $9.88 |
| 3. | Sharps Technology, Inc. | $1.84 | — | $73.85 M | — | -452.36% | -2.03% | $18.23 / $1.42 | $15.68 |
| 4. | OraSure Technologies, Inc. | $3.19 | — | $221.2 M | — | -18.75% | -18.3% | $3.82 / $2.08 | $4.84 |
| 5. | ICU Medical, Inc. | $130.58 | 4,461.76 | $3.27 B | — | 3.08% | 0.04% | $160.29 / $107 | $86.03 |
| 6. | BioLife Solutions, Inc. | $22.19 | — | $1.04 B | — | -4.34% | -3.37% | $29.62 / $17.86 | $7.72 |
| 7. | STAAR Surgical Company | $25.53 | — | $1.27 B | — | -11.99% | -21.7% | $30.81 / $15.59 | $6.97 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 9.04 M | 9.81 M | 9.95 M | 9.71 M | 9.16 M |
| Operating Profit | 2.44 M | 2.61 M | 3.2 M | 3.47 M | 2.93 M |
| Net Profit | 2.57 M | 2.63 M | 3.05 M | 3.04 M | 2.9 M |
| EPS in Rs | 0.81 | 0.83 | 0.96 | 0.95 | 0.91 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 38.52 M | 40.9 M | 50.22 M | 52.28 M |
| Operating Profit | 11.4 M | 13.59 M | 16.78 M | 19.79 M |
| Net Profit | 11.29 M | 13.87 M | 16.64 M | 16.47 M |
| EPS in Rs | 3.54 | 4.36 | 5.22 | 5.17 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 122.54 M | 122.54 M | 135.46 M | 123.87 M |
| Total Liabilities | 3.27 M | 5.11 M | 7.14 M | 9.62 M |
| Equity | 119.27 M | 117.43 M | 128.31 M | 114.25 M |
| Current Assets | 97.74 M | 96.33 M | 106.27 M | 89.92 M |
| Current Liabilities | 2.6 M | 3.76 M | 4.71 M | 5.96 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 14.69 M | 14.83 M | 22.28 M | 21.15 M |
| Investing CF | -0.37 M | -0.21 M | -0.64 M | -0.82 M |
| Financing CF | -12.34 M | -23.84 M | -4.17 M | -5.48 M |
| Free CF | 14.32 M | 14.6 M | 21.64 M | 20.33 M |
| Capex | -0.37 M | -0.23 M | -0.64 M | -0.82 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -18.56% | -3.93% | — | — |
| Earnings Growth % | -16.6% | 0.98% | — | — |
| Profit Margin % | 33.92% | 33.12% | 31.51% | — |
| Operating Margin % | 33.23% | 33.4% | 37.85% | — |
| Gross Margin % | 59.03% | 59.81% | 61.58% | — |
| EBITDA Margin % | 40.19% | 46.08% | 51.4% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-03-17 | $0.31 |
| 2025-12-16 | $0.31 |
| 2025-09-17 | $0.305 |
| 2025-06-16 | $0.305 |
| 2025-03-14 | $0.305 |
Stock Splits
No stock split history available.